Sign up for the email list
"Thank you again for last night. Everyone was very glad they came and feel so much better about things now. There were many compliments given about you... Carin
UCB announces FDA approval for Keppra in infants and children from one month of age with partial onset seizures01/26/2012
UCB announced today that the U.S. Food and Drug Administration (FDA) has approved Keppra® (levetiracetam) tablets and oral solution as adjunctive therapy in the treatment of partial onset seizures in adults and children one month of age and older with epilepsy. Keppra® was previously approved in the U.S. as adjunctive therapy for partial onset seizures in adults and children four years of age and older with epilepsy.
Back To All News